Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells

Redox Report

Volumn 12, Issue 1-2, 2007, Pages 50-54

  Borovic, Suzana ^a   Cipak, Ana ^a   Meinitzer, Andreas ^b   Kejla, Zvonko ^c   Perovic, Darko ^c   Waeg, Georg ^d   Zarkovic, Neven ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b LKH   (Austria)

^c Klinika za traumatologiju Zagreb   (Croatia)

^d UNIVERSITY OF GRAZ   (Austria)

Author keywords

4 hydroxynonenal; Apoptosis; Glutathione; HNE His ELISA; Human osteoblasts; Human osteosarcoma; Mesenchymal cells

Indexed keywords

4 HYDROXYNONENAL; CELL PROTEIN; GLUTATHIONE;

APOPTOSIS; BINDING AFFINITY; CANCER CELL CULTURE; CANCER GROWTH; CELL GROWTH; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH REGULATION; HOMEOSTASIS; HUMAN; HUMAN CELL; MESENCHYME CELL; NICK END LABELING; OSTEOBLAST; OSTEOSARCOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

ALDEHYDES; APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; FIBROBLASTS; HUMANS; MESODERM; NEOPLASM PROTEINS; OSTEOSARCOMA; PROTEINS; REFERENCE VALUES;

EID: 33846807884     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100007X162194     Document Type: Conference Paper

References (24)

1. Burcham PC. Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts. Mutagenesis 1998; 13: 287-305.
2. Pennington JD, Cheng Wang TJ, Nguyen P et al. Redox-sensitive signaling factors as a novel molecular targets for cancer therapy. Drug Resist Update 2005; 8: 322-330.
3. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995; 358: 1-3.
4. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
5. Chiarpotto E, Allasia C, Biasi F et al. Down-modulation of nuclear localisation and pro-fibrogenic effect of 4-hydroxy-2,3-nonenal by thiol- and carbonyl-reagents. Biochim Biophys Acta 2002; 1584: 1-8.
6. Calonghi N, Boga C, Cappadone C et al. Cytotoxic and cytostatic effects induced by 4-hydroxynonenal in human osteosarcoma cells. Biochem Biophys Res Commun 2002; 293: 1502-1507.
7. Borovic Sunjic S, Cipak A, Wildburger R, Zarkovic N. The influence of 4-hydroxy-2-nonenal on proliferation and differentiation of human osteosarcoma cells. BioFactors 2005; 24: 141-148.
8. Sovic A, Borovic, S, Loncaric I et al. The carcinostatic and proapoptotic potential of 4-hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins. Anticancer Res 2001; 21: 1997-2004.
9. Borovic S, Rabuzin F, Waeg G, Zarkovic N. Enzyme-linked immunosorbent assay for 4-hydroxynonenal-protein conjugates. Free Radic Res 2006; 40: 809-820.
10. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 1969; 27: 502-522.
11. Semlitsch T, Tillian IM, Zarkovic N et al. Differential influence of the lipid peroxidation product 4-hydroxynonenal on the growth of human lymphatic leukaemia cells and human peripheral blood lymphocytes. Anticancer Res 2002; 22: 1689-1697.
12. Biasi F, Tessitore L, Zanetti D et al. Associated changes of lipid peroxidation and transforming growth factor beta 1 levels in human colon cancer during tumour progression. Gut 2002; 50: 361-367.
13. Kondo S, Toyokuni S, Iwasa Y et al. Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic Biol Med 1999; 27: 401-410.
14. Oberley TD, Toyokuni S, Szweda LI. Localization of hydroxynonenal protein adducts in normal human kidney and selected human kidney cancers. Free Radic Biol Med 1999; 27: 695-703.
15. Laurent A, Perdu-Duran E, Alary J, Debrauwer L, Cravedi JP. Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices. Toxicol Lett 2000; 114: 203-214.
16. Lee YY, Kim HG, Jung HI et al. Activities of antioxidant and redox enzymes in human normal hepatic and hepatoma cell lines. Mol Cell 2002; 31: 305-311.
17. Syng-ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 2004; 3: 1101-1108.
18. Vartak S, McCaw R, Davis CS, Robbins MEC, Spector AA. Gamma-linolenic acid (GLA) is cytotoxic to 36B10 malignant rat astrocytoma but not to normal rat astrocytes. Br J Cancer 1998; 77: 1612-1620.
19. Husbeck B, Nonn L, Peehl DM, Knox SJ. Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells. Prostate 2006; 66: 218-225.
20. Forman HJ, Dickinson DA, Iles KE. HNE - signaling pathways leading to its elimination. Mol Asp Med 2003; 24: 189-194.
21. Hubatsch I, Ridderström M, Mannervik B. Human glutathione transferase A4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem J 1998; 215: 175-179.
22. Singhal SS, Zimniak P, Awasthi S et al. Several closely related glutathione S-transferase isozymes catalyzing conjugation of 4-hydroxynonenal are differentially expressed in human tissues. Arch Biochem Biophys 1994; 311: 242-250.
23. Awasthi S, Sharma R, Singhal SS et al. RLIP76, a novel transporter catalyzing ATP-dependent efflux of xenobiotics. Drug Metab Dispos 2002; 30: 1300-1310.
24. Awasthi YC, Yang Y, Tiwari NK et al. Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases. Free Radic Biol Med 2004; 37: 607-619.